Physician

Wasif Shirazi, M.D.

According to 2025 Medicare claims, Wasif Shirazi, M.D. (NPI: 1558336149) practices hematology/oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is AFFILIATED ONCOLOGISTS, LLC (NPI: 1225314362; TIN: 274182621) and primary practice location at 60462-3207. Shirazi is affiliated with the AMITA Health Accountable Care Organization, LLC (ACO ID: A1501), participating under the MSSP model.

Shirazi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 927 traditional Medicare patients, billed 327,657 HCPCS/CPT codes, and received $5,280,659 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,055 prescription claims across 195 beneficiaries totaling $3,401,411 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 12 claims. Open Payments data shows 154 records totaling $3,929. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,420,707 to $5,280,659. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,293,502 to $3,401,411. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.3M2015 Medicare payment: $2,420,707 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,430,437 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,560,710 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,242,372 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,840,077 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,018,828 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,125,958 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,639,422 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,294,532 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,280,659 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015653271,690$2,420,707
2016752301,157$2,430,437
2017848421,758$3,560,710
2018846257,238$3,242,372
2019839189,672$2,840,077
2020811210,849$3,018,828
2021919247,730$3,125,958
2022855287,812$3,639,422
2023869357,885$4,294,532
2024927327,657$5,280,659

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.7M$3.4M2015 Drug cost: $1,293,502 (USD; Tot_Drug_Cst)2016 Drug cost: $1,570,205 (USD; Tot_Drug_Cst)2017 Drug cost: $1,434,397 (USD; Tot_Drug_Cst)2018 Drug cost: $1,943,647 (USD; Tot_Drug_Cst)2019 Drug cost: $2,284,608 (USD; Tot_Drug_Cst)2020 Drug cost: $2,853,597 (USD; Tot_Drug_Cst)2021 Drug cost: $3,278,907 (USD; Tot_Drug_Cst)2022 Drug cost: $3,178,274 (USD; Tot_Drug_Cst)2023 Drug cost: $3,366,852 (USD; Tot_Drug_Cst)2024 Drug cost: $3,401,411 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015150881$1,293,502
2016127891$1,570,205
2017162976$1,434,397
2018141882$1,943,647
2019138845$2,284,608
2020145883$2,853,597
20211771,012$3,278,907
20221881,124$3,178,274
2023188939$3,366,852
20241951,055$3,401,411

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$9.7K$19K2015 Medicare payment: $19,318 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $5,295 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,266 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $2,084 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201522188$19,318
2016N/R66$5,295
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R29$2,266
2022N/RN/RN/R
2023N/R12$2,084
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less160605$104
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more286566$98
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more328551$67
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's232371$13
96372Injection of drug or substance under skin or into muscle190583$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide511,365$793,505
CalquenceAcalabrutinib Maleate31930$446,273
BrukinsaZanubrutinib22660$345,753
VenclextaVenetoclax17500$198,902
EliquisApixaban1527,800$148,324

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.154$3,929PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Wasif Shirazi, M.D.?

Tedicare shows public-source Medicare data for Wasif Shirazi, M.D. (NPI 1558336149), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wasif Shirazi, M.D. have ACO affiliation data?

Wasif Shirazi, M.D. is shown with ACO affiliation data for AMITA Health Accountable Care Organization, LLC (MSSP, ACO ID A1501).

What billing organization is linked to Wasif Shirazi, M.D.?

Wasif Shirazi, M.D. is linked to AFFILIATED ONCOLOGISTS, LLC (billing NPI 1225314362) in the available physician profile data.

Does Wasif Shirazi, M.D. have Open Payments data?

Wasif Shirazi, M.D. has 154 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.